Orofacial Granulomatosis and Crohn Disease: Coincidence or Pattern? A Systematic Review

Carregando...
Imagem de Miniatura
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
KARGER
Autores
FLOREZI, Giovanna Piacenza
DABRONZO, Maria Luiza Ducati
LOURENCO, Silvia Vanessa
Citação
DERMATOLOGY, v.237, n.4, p.635-640, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: To systematically review all cases of orofacial granulomatosis (OFG) and evaluate the association between OFG and Crohn disease (CD). Summary: This review was conducted according to PRISMA guidelines and a search of the PubMed, MEDLINE, and Embase databases, and the Cochrane Library in March 2020, using keywords and MeSH terms associated with ""orofacial granulomatosis,"" ""Crohn disease,"" and their variants, with no language restrictions and across all age groups. All relevant articles were accessed in full text. Single case reports and articles on sarcoidosis, allergy, ulcerative colitis, and infectious diseases were excluded from the analysis. Results: We retrieved 507 reports on OFG. The mean age at onset was 23.3 years (range 2-89 years). A total of 240 (47.3%) females and 267 (52.6%) males were included. CD was present in 93 children aged <16 years (68.3%) and in 43 adults (31.9%). In most cases, the OFG appeared before the CD. The most common clinical manifestations were intraoral mucosa abnormalities (n = 251; 49.5%), lower-lip swelling (n = 249; 49.1%), upper-lip swelling (n = 227; 44.7%), and gingivae (n = 193; 38.7%). Patients with concurrent CD were more likely to experience involvement of the buccal sulcus. Key Messages: OFG presents primarily as a solo entity. The OFG that was associated with CD was present in 93 children aged under 16 years (68.3%) and in 43 adults (31.9%). Childhood onset of OFG carries with it a higher risk of developing CD.
Palavras-chave
Crohn disease, Orofacial granulomatosis, Tongue, fissured, Facial paralysis, Granulomatosis, orofacial
Referências
  1. Campbell H, 2011, INFLAMM BOWEL DIS, V17, P2109, DOI 10.1002/ibd.21599
  2. Elias MK, 2013, J NEUROL, V260, P138, DOI 10.1007/s00415-012-6603-6
  3. Fitzpatrick L, 2011, J ORAL PATHOL MED, V40, P10, DOI 10.1111/j.1600-0714.2010.00957.x
  4. Gale G, 2015, ORAL DIS, V21, pE98, DOI 10.1111/odi.12236
  5. Gavioli CFB, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2020.103879
  6. Grave B, 2009, ORAL DIS, V15, P46, DOI 10.1111/j.1601-0825.2008.01500.x
  7. Haaramo A, 2017, J PEDIATR GASTR NUTR, V65, P388, DOI 10.1097/MPG.0000000000001554
  8. Hornstein O P, 1973, Curr Probl Dermatol, V5, P117
  9. Lankarani KB, 2013, WORLD J GASTROENTERO, V19, P8571, DOI 10.3748/wjg.v19.i46.8571
  10. Lazzerini M, 2015, DIGEST LIVER DIS, V47, P338, DOI 10.1016/j.dld.2014.12.012
  11. Lazzerini M, 2014, WORLD J GASTROENTERO, V20, P7497, DOI 10.3748/wjg.v20.i23.7497
  12. Liu RZ, 2013, J CLIN NEUROSCI, V20, P993, DOI 10.1016/j.jocn.2012.10.009
  13. Lourenco SV, 2010, J EUR ACAD DERMATOL, V24, P204, DOI 10.1111/j.1468-3083.2009.03304.x
  14. Marcoval J, 2012, OR SURG OR MED OR PA, V113, pE12, DOI 10.1016/j.oooo.2011.10.011
  15. Moher D, 2009, ANN INTERN MED, V151, P264, DOI [10.7326/0003-4819-151-4-200908180-00135, 10.1016/j.ijsu.2010.02.007]
  16. Mutalib M, 2016, WORLD J PEDIATR, V12, P421, DOI 10.1007/s12519-016-0045-7
  17. Ratzinger G, 2007, J EUR ACAD DERMATOL, V21, P1065, DOI 10.1111/j.1468-3083.2007.02194.x
  18. Saalman R, 2009, ACTA PAEDIATR, V98, P1162, DOI 10.1111/j.1651-2227.2009.01295.x
  19. Sanderson J, 2005, INFLAMM BOWEL DIS, V11, P840, DOI 10.1097/01.MIB.0000178261.88356.67
  20. Sciubba JJ, 2003, J ORAL PATHOL MED, V32, P576, DOI 10.1034/j.1600-0714.2003.t01-1-00056.x
  21. Tuxen AJ, 2010, AUSTRALAS J DERMATOL, V51, P124, DOI 10.1111/j.1440-0960.2010.00627.x
  22. van der Waal RIF, 2002, INT J DERMATOL, V41, P225, DOI 10.1046/j.1365-4362.2002.01466.x
  23. WIESENFELD D, 1985, Q J MED, V54, P101